Global Huber Needle Market to Grow at a CAGR of 6% During 2021-2026, Aided by the Increasing Investments in Healthcare Infrastructure

North America has been a leading market of huber needles in the historical period and is expected to retain its position over the forecast period. This dominance can be attributed to the rising number of patients with chronic diseases. The adoption of huber needles in the treatment of HIV and hepatitis is expected to bolster the market further. Huber needles have also become indispensable in the chemotherapy procedures. Thus, the rising adoption of the product across the healthcare segments in North America is expected to aid the market growth in the region. The huber needles market is also growing rapidly in India owing to the growing oncological advancements. Meanwhile, curved huber needles are being preferred for repetitive vascular access procedures globally.

Becton, Dickinson, and Company (NYSE: BDX), a leading player in the industry, has a wide range of huber needles, which are focussed on providing comfort of use to both the clinicians and patients, making it easier for the clinicians to dress and monitor the site of insertion. With consumers increasingly prioritising comfort and ease of use, these factors are expected to strengthen the company’s position within the market. Manufacturers of huber needles are also promoting lubricated huber needles, which reduce the penetration force and pain caused.

Market Analysis by Type, Application, End Use, and Region:

• Based on type, the market is broadly classified into straight and curved huber needles.
• The market based on the application can be divided into dialysis, blood transfusions, IV cancer treatment, lap-band adjustments, and home parental nutrition, among others.
• Based on end-use, the market is categorised into hospitals, ambulatory surgical centres, oncology centres, and clinics, among others.
• The regional markets for huber needle include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

• The huber needle industry is being driven by the rise in chronic patients across the globe.
• A rapid increase in cancers and blood transfusion is also accelerating the industry growth.
• The market is expected to receive a further boost from the growing R&D activities and increased health care investments in the developing nations.
• The usage in treatments of hepatitis and HIV is further aiding the growth of the overall market.
• Furthermore, government regulations on needle stick injuries to ensure patient safety is expected to bolster the huber needle industry over the forecast period. 

Key Offerings of the Report:

• The EMR report gives an overview of the global market for huber needle for the periods (2016-2020) and (2021-2026).
• The report also offers the historical (2016-2020) and forecast (2021-2026) markets for the types, applications, end-uses, and major regions of huber needle.
• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global huber needle market are Baxter International Inc., Becton, Dickinson, and Company, NIPRO Corporation, B. Braun Medical Inc., and Smiths Medical Group Limited, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.